Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety, pharmacokinetics, and activity of RO7790121 in participants with advanced nonalcoholic steatohepatitis (MASH)–related l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• RO7790121

Snippet

Sponsor: Hoffmann-La Roche | Conditions: MASH | Phase 1 | Status: ACTIVE_NOT_RECRUITING